Skip to main content
. 2016 Feb 18;27(6):1068–1074. doi: 10.1093/annonc/mdw073

Figure 1.

Figure 1.

Diagram of patient testing and trial allocation on ATTACC. The eligible biomarker population was defined as a biomarker result that met an ATTACC-companion trial eligibility.